Top Markets
Coin of the day
IRRAS AB (publ) IRRAS AB (publ)

IRRAS AB (publ)

IRRAS
株式のランク #29628
IRRAS AB (publ), a medical technology company established in 2011 and... IRRAS AB (publ), a medical technology company established in 2011 and headquartered in Stockholm, Sweden, is dedicated to developing medical solutions that enhance the lives of critically ill patients globally. The firm specializes in neurocritical care products, aiming to transform patient outcomes and address complexities inherent in current treatment methods. Among its offerings is IRRAflow, an advanced irrigating intracranial drainage system that integrates controlled drainage, automated irrigation, and continuous intracranial pressure (ICP) monitoring, used effectively for treating hemorrhagic strokes and chronic subdural hematoma. Additionally, IRRAS provides the Hummingbird ICP monitoring system, comprising the HICP200 Control Module and various catheters like the H610 for quad ICP monitoring with drainage and the H110 for solo ICP monitoring. These Hummingbird neuromonitoring tools are vital for managing patients with elevated ICP caused by conditions such as traumatic brain injury, subarachnoid hemorrhage, and strokes. The company distributes its products to hospitals through both its direct sales force and a network of strategic distribution partners.
株価
$0.01791564
最終同期: 2023-11-03
時価総額
$20.30M
変化(1日)
22.81%
変化(1年)
0.00%
SE
取引 IRRAS AB (publ) (IRRAS)

カテゴリー

IRRAS AB (publ)(IRRAS)の利益
2026 時点の利益 TTM: 0
IRRAS AB (publ) の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
IRRAS AB (publ) の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
- -
DE